These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1689384)

  • 1. Postoperative immunotherapy of murine C1300-neuroblastoma.
    Fowler CL; Brooks SP; Rossman JE; Cooney DR
    J Pediatr Surg; 1990 Feb; 25(2):229-37. PubMed ID: 1689384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined preoperative and postoperative immunotherapy for murine C1300 neuroblastoma.
    Fowler CL; Brooks SP; Rossman JE; Cooney DR
    J Pediatr Surg; 1993 Mar; 28(3):420-6; discussion 426-7. PubMed ID: 8468657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced resection and improved survival in murine neuroblastoma (C1300-NB) after preoperative immunotherapy.
    Fowler CL; Brooks SP; Squire R; Rich GA; Rossman JE; Finegold MJ; Allen JE; Cooney DR
    J Pediatr Surg; 1991 Apr; 26(4):381-7; discussion 387-8. PubMed ID: 2056397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
    Naito K; Nomi S; Komichi H; Ueda Y; Yamagishi H; Oka T; Pellis NR; Kahan BD
    Cancer Detect Prev; 1992; 16(5-6):321-7. PubMed ID: 1361881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interferon on C1300 mouse neuroblastoma.
    Tozawa M; Kidowaki T; Tanaka T; Sawada T; Kusunoki T; Oku T; Kishida T
    Cancer Treat Rep; 1982 Jul; 66(7):1575-7. PubMed ID: 6178506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of the immunoregulation of murine neuroblastoma.
    Choi SH; Reynolds JV; Ziegler MM
    J Pediatr Surg; 1989 Jan; 24(1):15-9; Discussion 19-20. PubMed ID: 2524562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma.
    Yang R; Reilly CR; Rescorla FJ; Sanghvi NT; Fry FJ; Franklin TD; Grosfeld JL
    J Pediatr Surg; 1992 Feb; 27(2):246-50; discussion 250-1. PubMed ID: 1564625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of interleukin-2 immunotherapy with L-arginine.
    Lieberman MD; Nishioka K; Redmond HP; Daly JM
    Ann Surg; 1992 Feb; 215(2):157-65. PubMed ID: 1546902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of optimal therapy for neuroblastoma: a study of the immunomodulatory effects of surgery and irradiation in the murine C1300 neuroblastoma model.
    Topalian SL; Ziegler MM
    J Surg Oncol; 1987 Feb; 34(2):120-7. PubMed ID: 2949117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of type III pneumococcal polysaccharide-specific suppressor T cells in cyclophosphamide-treated mice requirement for recognition of antigen and I-J determinants on antigen coupled to syngeneic spleen cells.
    Braley-Mullen H
    J Immunol; 1983 Nov; 131(5):2190-5. PubMed ID: 6195257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy.
    Sigal RK; Lieberman MD; Reynolds JV; Shou J; Ziegler MM; Daly JM
    J Pediatr Surg; 1991 Apr; 26(4):389-95; discussion 395-6. PubMed ID: 1905348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated regression of 'metastatic' neuroblastoma in the liver.
    Ishizu H; Bove KE; Ziegler MM; Arya G
    J Pediatr Surg; 1994 Feb; 29(2):155-9; discussion 159-60. PubMed ID: 8176585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
    Heczey A; Louis CU; Savoldo B; Dakhova O; Durett A; Grilley B; Liu H; Wu MF; Mei Z; Gee A; Mehta B; Zhang H; Mahmood N; Tashiro H; Heslop HE; Dotti G; Rooney CM; Brenner MK
    Mol Ther; 2017 Sep; 25(9):2214-2224. PubMed ID: 28602436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cyclophosphamide on neuroblastoma and the bone marrow function in the experimental studies].
    Ohkawa M
    Hokkaido Igaku Zasshi; 1983 Nov; 58(6):561-74. PubMed ID: 6368346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.
    Lode HN; Dreier T; Xiang R; Varki NM; Kang AS; Reisfeld RA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2475-80. PubMed ID: 9482910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells.
    Berd D; Mastrangelo MJ
    Cancer Res; 1988 Mar; 48(6):1671-5. PubMed ID: 2830969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model.
    Castano AP; Mroz P; Wu MX; Hamblin MR
    Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5495-500. PubMed ID: 18378905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.